1 / 7

Global Huntington's Disease Therapeutics Market 2014-2018

Big Market Research has announced a new Report Package "Global Huntington's Disease Therapeutics Market -Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential"<br><br>Get Complete Details At: http://www.bigmarketresearch.com/global-huntingtons-disease-therapeutics-2014-2018-market<br><br>Huntington's disease is a progressive neurodegenerative disorder that can be inherited from one generation to another as an autosomal dominant trait. It arises due to genetically programmed degeneration of neurons in some parts of the brain such as basal ganglia and cerebral cortex.<br><br>Enquire At: http://www.bigmarketresearch.com/report-enquiry/144058

kiarakempt
Télécharger la présentation

Global Huntington's Disease Therapeutics Market 2014-2018

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Huntington's Disease Therapeutics Market 2014-2018 Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2018 Published Date: Oct 2014

  2. Report Description Huntington's disease is a progressive neurodegenerative disorder that can be inherited from one generation to another as an autosomal dominant trait. It arises due to genetically programmed degeneration of neurons in some parts of the brain such as basal ganglia and cerebral cortex. Basal ganglia plays an important role in coordinating movement while cerebral cortex regulates perception, thought, and memory. Degeneration of neurons leads to progressive cognitive impairment and dementia. People with Huntington's disease often develop chorea that causes involuntary muscle movements of hands, face, trunk, and feet. The behavioural disorders associated with the disease include depression, psychosis, and changes in personality. Other symptoms of the disease include speech impairment, anxiety, stress, and difficulty in swallowing. Get Complete Report At: http://www.bigmarketresearch.com/global-huntingtons-disease-therapeutics-2014-2018-market People suffering from Huntington's disease usually develop symptoms in their mid-30s and 40s. However, in few cases, disease symptoms appear in childhood or teens. The former case represents the adult-onset form of the disease, while the latter is the early-onset form. The early-onset form is associated with symptoms such as tremors, slow movements, and rigidity. Children with early-onset disease rarely live to adulthood. Currently, there is no approved treatment for Huntington's disease. The Global Huntington's Disease Therapeutics market to grow at a CAGR of 29.46 percent over the period 2013-2018.

  3. Report Description Covered in this Report This report covers the present scenario and the growth prospects of the Global Huntington's Disease Therapeutics market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of drugs approved for the treatment of symptoms of Huntington's disease. The Global Huntington's Disease Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Huntington's Disease Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Enquire About This Report At: http://www.bigmarketresearch.com/report-enquiry/144058 Key Regions • Americas • APAC • EMEA Key Vendors • Lundbeck • Valeant Pharmaceuticals International

  4. Report Description Other Prominent Vendors • Auspex Pharmaceuticals • GlaxoSmithKline • Ipsen • Omeros • Palobiofarma • Pfizer • Prana Biotechnology • Raptor Pharmaceutical • Siena Biotech • SOM Biotech • Teva Pharmaceutical Industries Market Driver • Unmet Medical Needs • For a full, detailed list, view our report Market Challenge • Poor Diagnosis Rates • For a full, detailed list, view our report Market Trend • Novel Mechanisms Targeted by Pipeline Candidates • For a full, detailed list, view our report

  5. Report Description Key Questions Answered in this Report • What will the market size be in 2018 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?

  6. Table Of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Prevalence of Huntington's Disease 07. Market Landscape 08. Market Segmentation by Drug Class 09. Geographical Segmentation 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape Get Complete TOC At: http://www.bigmarketresearch.com/global-huntingtons-disease-therapeutics-2014-2018-market

  7. FOR MORE DETAILS Visit us at : http://www.bigmarketresearch.com//global-huntingtons-disease-therapeutics-2014-2018-market Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: help@bigmarketresearch.com

More Related